- NanoViricides (NYSE:NNVC -3.2%) FQ1 results: Revenues: $0; R&D Expense: $0.8M (-33.3%); G&A: $0.9M (+28.6%); Operating Loss: ($1.7M) (+10.5%); Net Loss: ($0.2M) (+96.8%); EPS: $0 ;Quick Assets: $41.1M (12.0%).
- No guidance given.
NanoViricides net loss improves in FQ1
Recommended For You
More Trending News
About NNVC Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NNVC | - | - |
NanoViricides, Inc. |